Literature DB >> 12749994

The effects of dexmedetomidine and halothane on Fos expression in the spinal dorsal horn using a rat postoperative pain model.

Noriko Shimode1, Tetsuo Fukuoka, Masaaki Tanimoto, Chikara Tashiro, Atsushi Tokunaga, Koichi Noguchi.   

Abstract

We investigated the effect of an intrathecal injection of a selective alpha2 adrenergic receptor agonist, dexmedetomidine (Dex), and halothane anesthesia on Fos expression in the lumbar spinal dorsal horn after skin incision of the plantar surface of the hind paw, a postoperative pain model using rats. Fos immunoreactivity was induced particularly in the superficial layers of the spinal cord 2 h after surgery. Halothane anesthesia (0.5-1.5%) partially reversed Fos induction, but not in a dose-dependent manner. Preoperative spinal Dex (0.1-10 microg) dose-dependently reduced Fos immunoreactivity, while a relatively high dose of Dex (10 microg) was necessary to produce a profound effect. When used with halothane anesthesia, relatively low doses of Dex (1-3 microg) completely suppressed Fos induction in the superficial spinal layers. These findings indicate that preoperative Dex treatment may provide anesthesia that does not induce stress on spinal neurons.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12749994     DOI: 10.1016/s0304-3940(03)00309-4

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  12 in total

1.  Dexmedetomidine blocks thermal hyperalgesia and spinal glial activation in rat model of monoarthritis.

Authors:  Bo Xu; Wei-shi Zhang; Jia-le Yang; Hua Xu; Xiao-ming Deng; Yu-qiu Zhang
Journal:  Acta Pharmacol Sin       Date:  2010-04-05       Impact factor: 6.150

2.  Genetic Reporters of Neuronal Activity: c-Fos and G-CaMP6.

Authors:  Andrew E Hudson
Journal:  Methods Enzymol       Date:  2018-03-08       Impact factor: 1.600

3.  Optimal Dose of Intrathecal Dexmedetomidine in Lower Abdominal Surgeries in Average Indian Adult.

Authors:  Shagufta Naaz; Jahanara Bandey; Erum Ozair; Adil Asghar
Journal:  J Clin Diagn Res       Date:  2016-04-01

4.  A comparison of spinal Iba1 and GFAP expression in rodent models of acute and chronic pain.

Authors:  Alfonso Romero-Sandoval; Nu Chai; Nancy Nutile-McMenemy; Joyce A Deleo
Journal:  Brain Res       Date:  2008-05-11       Impact factor: 3.252

5.  Analgesic effects of dexmedetomidine in vincristine-evoked painful neuropathic rats.

Authors:  Hue Jung Park; Young Hoon Kim; Hyun Jung Koh; Chul-Soo Park; Seung-hee Kang; Jong-Ho Choi; Dong Eon Moon
Journal:  J Korean Med Sci       Date:  2012-10-30       Impact factor: 2.153

6.  Dexmedetomidine as an intrathecal adjuvant for postoperative analgesia.

Authors:  Rajni Gupta; Jaishri Bogra; Reetu Verma; Monica Kohli; Jitendra Kumar Kushwaha; Sanjiv Kumar
Journal:  Indian J Anaesth       Date:  2011-07

7.  A Comparative study of intrathecal dexmedetomidine and fentanyl as adjuvants to Bupivacaine.

Authors:  Rajni Gupta; Reetu Verma; Jaishri Bogra; Monica Kohli; Rajesh Raman; Jitendra Kumar Kushwaha
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2011-07

8.  Anti-nociceptive effect of dexmedetomidine in a rat model of monoarthritis via suppression of the TLR4/NF-κB p65 pathway.

Authors:  Dong Ji; Yalan Zhou; Shuangshuang Li; Dai Li; Hui Chen; Yuanchang Xiong; Yuqiu Zhang; Hua Xu
Journal:  Exp Ther Med       Date:  2017-09-22       Impact factor: 2.447

9.  A comparative study between intrathecal dexmedetomidine and fentanyl as adjuvant to intrathecal bupivacaine in lower abdominal surgeries: A randomized trial.

Authors:  Aamir Laique Khan; Raj Bahadur Singh; Rajni K Tripathi; Sanjay Choubey
Journal:  Anesth Essays Res       Date:  2015 May-Aug

10.  Evaluation of the neurotoxicity of intrathecal dexmedetomidine on rat spinal cord (electromicroscopic observations).

Authors:  Dilek Ozdamar; Huban Dayioglu; Ihsan Anik; Seyhun Solakoglu; Mine Solak; Kamil Toker
Journal:  Saudi J Anaesth       Date:  2018 Jan-Mar
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.